Am. J. Respir. Cell Mol. Biol., Vol 11, No. 3, 09 1994, 351-357.
Anti-transforming growth factor-beta monoclonal antibodies prevent lung injury in hemorrhaged mice
R Shenkar, WF Coulson and E Abraham
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver 80262.
Acute lung injury, characterized as the adult respiratory distress syndrome
(ARDS), is a common clinical occurrence following blood loss and injury. We
previously found increased levels of transforming growth factor (TGF)-beta
1 mRNA in murine intraparenchymal mononuclear cells and in alveolar
macrophages within 1 h after hemorrhage. Because TGF- beta has potent
proinflammatory and immunoregulatory properties, we investigated the effect
of blocking TGF-beta with mAb on hemorrhage- induced pathology, cytokine
mRNA levels in lungs, as well as survival from pneumonia. Mice treated with
anti-TGF-beta mAb showed normal pulmonary histology 3 days after hemorrhage
and resuscitation in contrast to the mononuclear and neutrophil
infiltrates, intraalveolar hemorrhage, and interstitial edema found in
hemorrhaged mice either treated with control antibody or not treated with
any antibody. Decreased mRNA levels for IL-1 beta, TNF-alpha, IL-6, IL-10,
and IFN- gamma as compared with untreated, hemorrhaged controls were
present in intraparenchymal pulmonary mononuclear cells following therapy
with anti-TGF-beta. In contrast, therapy with anti-TGF-beta increased mRNA
levels for IL-1 beta and TNF-alpha in alveolar macrophages and for TGF-
beta in peripheral blood mononuclear cells collected 3 days after
hemorrhage. Administration of anti-TGF-beta to hemorrhaged mice did not
correct the enhanced susceptibility to Pseudomonas aeruginosa pneumonia
that exists after hemorrhage. These results suggest that TGF-beta has an
important role in hemorrhage-induced acute lung injury, but does not
contribute to the post-hemorrhage depression in pulmonary antibacterial
response.
This article has been cited by other articles:

|
 |

|
 |
 
S. C. Wesselkamper, L. M. Case, L. N. Henning, M. T. Borchers, J. W. Tichelaar, J. M. Mason, N. Dragin, M. Medvedovic, M. A. Sartor, C. R. Tomlinson, et al.
Gene Expression Changes during the Development of Acute Lung Injury Role of Transforming Growth Factor {beta}
Am. J. Respir. Crit. Care Med.,
December 1, 2005;
172(11):
1399 - 1411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Kim, J. S. Park, D. Strassheim, I. Douglas, F. Diaz del Valle, K. Asehnoune, S. Mitra, S. H. Kwak, S. Yamada, I. Maruyama, et al.
HMGB1 contributes to the development of acute lung injury after hemorrhage
Am J Physiol Lung Cell Mol Physiol,
May 1, 2005;
288(5):
L958 - L965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christofidou-Solomidou, A. Scherpereel, R. Wiewrodt, K. Ng, T. Sweitzer, E. Arguiri, V. Shuvaev, C. C. Solomides, S. M. Albelda, and V. R. Muzykantov
PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress
Am J Physiol Lung Cell Mol Physiol,
August 1, 2003;
285(2):
L283 - L292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christofidou-Solomidou, S. Kennel, A. Scherpereel, R. Wiewrodt, C. C. Solomides, G. G. Pietra, J.-C. Murciano, S. A. Shah, H. Ischiropoulos, S. M. Albelda, et al.
Vascular Immunotargeting of Glucose Oxidase to the Endothelial Antigens Induces Distinct Forms of Oxidant Acute Lung Injury : Targeting to Thrombomodulin, But Not to PECAM-1, Causes Pulmonary Thrombosis and Neutrophil Transmigration
Am. J. Pathol.,
March 1, 2002;
160(3):
1155 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Huang, Q. Liu, F. E. Johnson, Y. Konish, and J. S. Huang
Transforming Growth Factor beta Peptide Antagonists and Their Conversion to Partial Agonists
J. Biol. Chem.,
October 24, 1997;
272(43):
27155 - 27159.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 American Thoracic Society.
|
|
|